Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
STING Activates a New Necroptosis Pathway That Drives Inflammatory Skin DiseaseLongevity & Aging

STING Activates a New Necroptosis Pathway That Drives Inflammatory Skin Disease

Researchers at the University of Cologne discovered that STING, the innate immune DNA sensor, can trigger a lethal inflammatory cell death program called necroptosis through ZBP1 — entirely independently of the previously known TNFR1 and FADD death receptor pathways. Using caspase-8-deficient mice and cells, they showed that DNA accumulation activates STING, which upregulates ZBP1 and MLKL, forming a novel ZBP1–RIPK1–RIPK3 complex that executes necroptosis. This pathway was confirmed to drive pathology in SAVI, a rare human interferonopathy caused by gain-of-function STING mutations, and blocking RIPK3 rescued disease in the preclinical SAVI mouse model. The findings identify STING-driven ZBP1-mediated necroptosis as a central disease mechanism and a promising therapeutic target.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.